Georg Lenz

23PUBLICATIONS
208CO-AUTHORS
Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Felix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile

|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

|Oct 28, 2024
Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs.

Imke E Karsten, Evgenii Shumilov, Norbert Schmitz

|Sep 16, 2024
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma.

Brandon S Willis, Kevin Mongeon, Hannah Dry

|Jun 04, 2024
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.

Julian Ronnacker, Marc-Andre Urbahn, Christian Reicherts

|May 03, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.

Philipp Berning, Lina Kolloch, Christian Reicherts

Pageof 4

Frequent Collaborators

5 joint publications

Matthias Stelljes

4 joint publications

Fabian Frontzek

4 joint publications

Christoph Schliemann

4 joint publications

Philipp Berning